Myriad Genetics, Inc. (MYGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
21.34+0.14 (+0.68%)
As of 1:19 PM EDT. Market open.
People also watch:
INCYPDLIVRTXNBIXALKS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open21.25
Prev Close21.20
Bid21.38 x 400
Ask21.39 x 400
Day's Range21.15 - 21.44
52wk Range19.10 - 46.24
1y Target EstN/A
Market Cap1.48B
P/E Ratio (ttm)12.48
Beta-0.04
Volume312,526
Avg Vol (3m)1,494,918
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: 2016 By the Numbers : August 23, 2016
    Capital Cubeyesterday

    Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: 2016 By the Numbers : August 23, 2016

    Categories: Yahoo Finance Get free summary analysis Myriad Genetics, Inc. reports financial results for the year ended June 30, 2016. We analyze the earnings along side the following peers of Myriad Genetics, Inc. – Genomic Health, Inc., Foundation Medicine, Inc., Vermillion, Inc., BioMarin Pharmaceutical Inc., Cepheid, Biocept, Inc., Bio-Rad Laboratories, Inc. Class A, Trovagene, Inc. and Interleukin Genetics, ... Read more (Read more...)

  • Weakness Seen in Myriad Genetics (MYGN) Estimates: Should You Stay Away?
    Zacks5 days ago

    Weakness Seen in Myriad Genetics (MYGN) Estimates: Should You Stay Away?

    Myriad Genetics (MYGN) should not be considered as it holds an unfavorable Zacks Rank and it has seen negative earnings estimate revisions.

  • American City Business Journals8 days ago

    EXCLUSIVE: Assurex Health buyer has a Cincinnati connection

    Myriad Genetics, the Utah firm that agreed to buy Mason-based Assurex Health in a deal that could be worth up to $410 million, has a Cincinnati connection. Dr. Rick Wenstrup, chief medical officer of Myriad (MYGN), helped invent the technology that Assurex Health’s genetic tests are based on when he was a professor at Cincinnati Children’s Hospital Medical Center. “To be with Myriad for 10 years after leaving Cincinnati Children’s Hospital and then see a company I was instrumental in starting as something we acquired is a pretty unusual situation and really quite gratifying,” Wenstrup said.